Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Alternative splicing and the epigenome in CML remission [WGBS]

ABSTRACT: Alternative splicing and the epigenome in CML remission [WGBS]

PROVIDER: PRJNA686439 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13274529_1.fastq.gz	Fastqsanger.gz
	SRR13274529_2.fastq.gz	Fastqsanger.gz
	SRR13274530_1.fastq.gz	Fastqsanger.gz
	SRR13274530_2.fastq.gz	Fastqsanger.gz
	SRR13274531_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Alternative splicing and the epigenome in CML remission

Project description:Alternative splicing and the epigenome in CML remission

| PRJNA686438 | ENA

Alternative splicing and the epigenome in CML remission [WGBS]

Project description:Transcriptomic and epigenomic profiling of matched CML diagnosis/remission samples revealed a reconfiguration of gene expression and DNA methylation at remission exhibiting patterns similar to those observed in healthy individuals. In contrast, alternative splicing retains chronic phase-like abnormal patterns. Most dramatic dissimilarities between remission and healthy control samples were observed in intron retention. While reduced DNA methylation around splice sites could explain increased intron retention at diagnosis, maintenance of high intron retention levels at remission has other causes, such as reduced splicing factor expression and histone modifications.

2020-12-19 | GSE163522 | GEO

Alternative splicing and the epigenome in CML remission [RNA-Seq]

Project description:Alternative splicing and the epigenome in CML remission [RNA-Seq]

| PRJNA602827 | ENA

Alternative splicing and the epigenome in CML remission [RNA-Seq]

2020-06-30 | GSE144119 | GEO

Alternative splicing and the epigenome in CML remission

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-12-19 | GSE163527 | GEO

Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons (WGBS)

Project description:Multiplex Epigenome Editing of MECP2 to Rescue Rett Syndrome Neurons (WGBS)

| PRJNA885846 | ENA

Dynamic antagonism between key repressive pathways maintains the placental epigenome (WGBS)

Project description:Dynamic antagonism between key repressive pathways maintains the placental epigenome (WGBS)

| PRJNA814664 | ENA

State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid Leukemia (CML)

Project description:Chronic myeloid leukemia (CML) is initiated and initially maintained solely by the fusion gene BCR-ABL, encoding a mutant protein targeted in the clinic with tyrosine kinase inhibitors (TKIs) While TKI treatment is effective in inducing long-term remission, frequently is not curative. For these reasons, CML is an ideal disease to test our hypothesis that that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We hypothesized that transcriptome-based state-transition models accurately predict cancer evolution and treatment response.

2023-11-02 | GSE244990 | GEO

An alternative pluripotent state confers interspecies chimaeric competency [WGBS]

Project description:In this study, we show that by simple modulation of extrinsic signaling pathways, a new class of pluripotent stem cells, referred to as region selective epiblast stem cells (rsEpiSCs), could be efficiently derived from different stages of the early embryo. rsEpiSCs share features of primed pluripotency yet are distinct from EpiSCs in their molecular characteristics and ability to colonize post-implantation embryos. We performed whole-genome bisulfite sequencing (WGBS) experiments to compare the DNA methylation landscapes of conventional EpiSCs and rsEpiSCs. Compare the DNA methylation profiles in 2 pluripotent stem cell types (LP-EpiSCs and conventional EpiSCs) in mouse. Two replicates are examined for each cell type.

2015-05-06 | E-GEOD-63568 | biostudies-arrayexpress

Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer [WGBS]

Project description:Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer [WGBS]

| PRJNA996580 | ENA